Bremelanotide Sq Injection bulk supplier for pharma manufacturers

Bremelanotide Sq Injection Suppliers & Bulk Manufacturers

Available Forms: Injection(SQ)

Available Strengths: 1.75 mg

Reference Brands: Vyleesi (US)

Category: Sexual Wellness

Bremelanotide Sq Injection is available in Injection(SQ) and strengths such as 1.75 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Bremelanotide Sq Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Bremelanotide Sq Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Product Description: Bremelanotide SQ injection, marketed as Vyleesi, is approved in the US by the FDA for premenopausal women with hypoactive sexual desire disorder (HSDD). In the EU, it remains under review or pending approval. Regulatory approval requires a detailed dossier including clinical efficacy, safety, manufacturing quality, and pharmacovigilance plans. In the US, the FDA rigorously reviews clinical trial data and manufacturing standards, while the EMA ensures compliance with regional safety and quality requirements. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring adherence to regional regulations supports timely approval and safe, effective availability of Bremelanotide worldwide.

Frequently Asked Questions

Yes, Bremelanotide Sq Injection is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Bremelanotide Sq Injection is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Shilajit Capsules/Tablet

Strength: 300 mg–600 mg per dose.

Form: Tablet/ Capsules

Reference Brands: Pure Himalayan Shilajit Resin(US)

View Details
Tribulus Terrestris Capsules

Strength: 500-750 mg

Form: Capsules

Reference Brands: Optimum Nutrition Tribulus(US)

View Details
Horny Goat Weed Capsules

Strength: 500–700 mg

Form: Capsules

Reference Brands: NOW Foods Horny Goat Weed(US)

View Details
Ashwagandha Capsules

Strength: 300-600 mg

Form: Capsules

Reference Brands: NOW Foods Ashwagandha

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.